Niravoline

Niravoline, also known as RU-51599, is a chemical compound with the formula .

Uses your system voice; voice and rate in settings.

Snapshot

≈ 5 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Niravoline, also known as RU-51599, is a chemical compound with the formula C
22
H
25
N
3
O
3
.[1] It has diuretic and aquaretic effects and has been studied for its potential use for cerebral edema[2] and cirrhosis.[3]

It exerts its pharmacological effect as a κ-opioid receptor agonist.[4] The drug produces hallucinogenic effects at high doses in humans.[5][6]

References

edit edit source
  1. ^ CID 9821174 from PubChem Wikipedia revision 1330408785, retrieved 2026-11-20
  2. ^ Guéniau, C.; Oberlander, C. (1997). "The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke". The Journal of Pharmacology and Experimental Therapeutics. 282 (1): 1–6. PMID 9223533. Wikipedia revision 1330408785, retrieved 2026-11-20
  3. ^ Gadano, A.; Moreau, R.; Pessione, F.; Trombino, C.; Giuily, N.; Sinnassamy, P.; Valla, D.; Lebrec, D. (2000). "Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis". Journal of Hepatology. 32 (1): 38–42. doi:10.1016/S0168-8278(00)80187-7. PMID 10673065. Wikipedia revision 1330408785, retrieved 2026-11-20
  4. ^ "Niravoline". NCI Thesaurus. National Cancer Institute. Wikipedia revision 1330408785, retrieved 2026-11-20
  5. ^ Farahbakhsh ZZ, Siciliano CA (January 2026). "Kappa opioid receptor control of motivated behavior revisited". Neuropsychopharmacology. 51 (2): 383–398. doi:10.1038/s41386-025-02226-9. PMC 12708679. PMID 41083597. Wikipedia revision 1330408785, retrieved 2026-11-20
  6. ^ Gadano A, Moreau R, Pessione F, Trombino C, Giuily N, Sinnassamy P, Valla D, Lebrec D (January 2000). "Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis". J Hepatol. 32 (1): 38–42. doi:10.1016/s0168-8278(00)80187-7. PMID 10673065. Wikipedia revision 1330408785, retrieved 2026-11-20
HallucinogensPsychedelics
(5-HT2A agonists)
  • For a full list of serotonergic psychedelics, see the navbox here and the list here instead.
Dissociatives
(NMDA antagonists)
  • For a full list of dissociatives, see the navbox here instead.
Deliriants
(mACh antagonists) KOR agonists GABAA agonists Oneirogens
(unknown mech.) Cannabinoids
(CB1 agonists)
  • For a full list of cannabinoids, see the navbox here and the list here instead.
Raw material Others Opioid receptor modulatorsμ-opioid
(MOR) δ-opioid
(DOR) κ-opioid
(KOR) Nociceptin
(NOP) Others
  • Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330408785 under CC BY-SA 4.0; modifications have been made.